π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The primary purpose of this study is to demonstrate the equivalence of bude...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-10-17
Trial ID
NCT06340581
The purpose of the study is to provide long term safety data of NVA237. Thi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-10
Trial ID
NCT01697696
Treatments Being Tested
This study investigated asthma-related quality of life in Brazilian patient...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-11
Trial ID
NCT00567476
The primary objective is to compare the effectiveness of maintenance therap...
Status
Completed
Location
HealthCore, Inc.
Start Date
2019-11-01
Trial ID
NCT04138758
Treatments Being Tested
The purpose of this study is to compare treatment with QVM149, an inhaler t...
Status
Withdrawn
Location
Robarts Research Insitute; The University of Western Ontario; London Health Sciences Centre
Start Date
2021-12-01
Trial ID
NCT04206761
Treatments Being Tested
There is large heterogeneity in treatment response to asthma medication and...
Status
Completed
Location
Universitair Ziekenhuis Antwerpen
Start Date
2018-06-12
Trial ID
NCT03654508
Treatments Being Tested
To assess the comparative effectiveness of combination Tiotropium and Oloda...
Status
Completed
Location
HealthCore, Inc.
Start Date
2019-11-01
Trial ID
NCT04184297
Asthma is one of the most common chronic diseases affecting children in the...
Status
Terminated
Location
BrightonNHS
Start Date
2017-07-01
Trial ID
NCT03269318
Treatments Being Tested
This is a randomized, double blind, placebo controlled, parallel-group, 7 d...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-09-20
Trial ID
NCT00964249
GW642444 and GSK233705 are in development for treatment of Chronic Obstruct...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-11-10
Trial ID
NCT00783003
Treatments Being Tested